It’s a good question. I don’t think us shareholders know what will be the next step even after a succesful trial results. You’d think there would be some kind of approval application to at least TGA, but who knows. I recall there was some talk about having to run another P3 in USA for approval there, but again the company never gave guidance on it so all speculation. It might not even matter because Cyp might just become a takeover target in the event of successful P3 results.
CYP Price at posting:
22.8¢ Sentiment: Buy Disclosure: Held
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)